Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. Issue 10 (8th November 2017)
- Record Type:
- Journal Article
- Title:
- Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. Issue 10 (8th November 2017)
- Main Title:
- Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism
- Authors:
- Wang, Yanan
Harding, Scott V.
Thandapilly, Sijo J.
Tosh, Susan M.
Jones, Peter J. H.
Ames, Nancy P. - Abstract:
- Abstract: Underlying mechanisms responsible for the cholesterol-lowering effect of β -glucan have been proposed, yet have not been fully demonstrated. The primary aim of this study was to determine whether the consumption of barley β -glucan lowers cholesterol by affecting the cholesterol absorption, cholesterol synthesis or bile acid synthesis. In addition, this study was aimed to assess whether the underlying mechanisms are related to cholesterol 7 α hydroxylase ( CYP7A1 ) SNP rs3808607 as proposed by us earlier. In a controlled, randomised, cross-over study, participants with mild hypercholesterolaemia ( n 30) were randomly assigned to receive breakfast containing 3 g high-molecular weight (HMW), 5 g low-molecular weight (LMW), 3 g LMW barley β -glucan or a control diet, each for 5 weeks. Cholesterol absorption was determined by assessing the enrichment of circulating 13 C-cholesterol over 96 h following oral administration; fractional rate of synthesis for cholesterol was assessed by measuring the incorporation rate of 2 H derived from deuterium oxide within the body water pool into the erythrocyte cholesterol pool over 24 h; bile acid synthesis was determined by measuring serum 7 α -hydroxy-4-cholesten-3-one concentrations. Consumption of 3 g HMW β -glucan decreased total cholesterol (TC) levels ( P =0·029), but did not affect cholesterol absorption ( P =0·25) or cholesterol synthesis ( P =0·14). Increased bile acid synthesis after consumption of 3 g HMW β -glucan wasAbstract: Underlying mechanisms responsible for the cholesterol-lowering effect of β -glucan have been proposed, yet have not been fully demonstrated. The primary aim of this study was to determine whether the consumption of barley β -glucan lowers cholesterol by affecting the cholesterol absorption, cholesterol synthesis or bile acid synthesis. In addition, this study was aimed to assess whether the underlying mechanisms are related to cholesterol 7 α hydroxylase ( CYP7A1 ) SNP rs3808607 as proposed by us earlier. In a controlled, randomised, cross-over study, participants with mild hypercholesterolaemia ( n 30) were randomly assigned to receive breakfast containing 3 g high-molecular weight (HMW), 5 g low-molecular weight (LMW), 3 g LMW barley β -glucan or a control diet, each for 5 weeks. Cholesterol absorption was determined by assessing the enrichment of circulating 13 C-cholesterol over 96 h following oral administration; fractional rate of synthesis for cholesterol was assessed by measuring the incorporation rate of 2 H derived from deuterium oxide within the body water pool into the erythrocyte cholesterol pool over 24 h; bile acid synthesis was determined by measuring serum 7 α -hydroxy-4-cholesten-3-one concentrations. Consumption of 3 g HMW β -glucan decreased total cholesterol (TC) levels ( P =0·029), but did not affect cholesterol absorption ( P =0·25) or cholesterol synthesis ( P =0·14). Increased bile acid synthesis after consumption of 3 g HMW β -glucan was observed in all participants ( P =0·049), and more pronounced in individuals carrying homozygous G of rs3808607 ( P =0·033). In addition, a linear relationship between log (viscosity) of β -glucan and serum 7 α- HC concentration was observed in homozygous G allele carriers. Results indicate that increased bile acid synthesis rather than inhibition of cholesterol absorption or synthesis may be responsible for the cholesterol-lowering effect of barley β -glucan. The pronounced TC reduction in G allele carriers of rs3808607 observed in the previous study may be due to enhanced bile acid synthesis in response to high-viscosity β -glucan consumption in those individuals. … (more)
- Is Part Of:
- British journal of nutrition. Volume 118:Issue 10(2017)
- Journal:
- British journal of nutrition
- Issue:
- Volume 118:Issue 10(2017)
- Issue Display:
- Volume 118, Issue 10 (2017)
- Year:
- 2017
- Volume:
- 118
- Issue:
- 10
- Issue Sort Value:
- 2017-0118-0010-0000
- Page Start:
- 822
- Page End:
- 829
- Publication Date:
- 2017-11-08
- Subjects:
- β-Glucan, -- CYP7A1, -- Molecular weight, -- Viscosity, -- Cholesterol, -- Bile acids, -- Mechanisms
Nutrition -- Periodicals
572.4 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=BJN ↗
- DOI:
- 10.1017/S0007114517002835 ↗
- Languages:
- English
- ISSNs:
- 0007-1145
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library STI - ELD Digital store
- Ingest File:
- 5666.xml